FDA Launches Real-Time Adverse Event Reporting Dashboard for Cosmetic Products - Food & Drug Administration
The U.S. Food and Drug Administration today announced the launch of the FDA Adverse Event Reporting System (FAERS) Public Dashboard for Cosmetic Products, an interactive tool designed to facilitate the public’s ability to query real-time adverse event data on cosmetic products. The user-friendly platform allows users to download report listings or data sets, with reports being updated daily to include the most recent submissions.
Today’s launch marks another step in the FDA’s modernization strategy, which includes radical transparency. It follows the agency’s recent announcement on real-time reporting of adverse event and medication errors data for drugs and therapeutic biologics.
“Americans are rightfully demanding greater insight into the safety and regulation of the cosmetic products they use every day. This real-time dashboard is a great step in our efforts to deliver greater transparency and allow the public to help identify potential data signals,” said FDA Commissioner Marty Makary, M.D., M.P.H.
The dashboard is dedicated exclusively to reports of cosmetic product adverse events, making the data easier to search. It includes serious adverse event reports submitted by responsible persons for cosmetic products under requirements established by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), as well as voluntary adverse event reports submitted to the FDA by healthcare professionals, consumers, salon professionals, cosmetologists and others. The FAERS dashboard contains adverse event reports for cosmetic products, such as moisturizers, shampoos, conditioners, hair dyes and tattoos.
Users can search and view reports using various search terms including the product name and adverse event term. Additionally, users can filter and sort results by different criteria, such as severity level of the adverse event, date or report type. This comprehensive search capability ensures that users can efficiently locate the specific information they need from the database.
Reports in this dashboard have not been verified by the FDA, and their publication does not indicate that the FDA has concluded the product caused the adverse event. Additionally, the FAERS data is not an indicator of the safety profile of the cosmetic product. To learn more, read the frequently asked questions.
For information about reporting adverse events, visit MedWatch, the FDA’s medical product safety reporting program for health professionals, patients and consumers.
________________________________________________________________________________
Federal Register Notices:
• Antidumping or Countervailing Duty Investigations, Orders, or Reviews: Certain Carbon and Alloy Steel Cut-to-Length Plate From Italy: Notice of Court Decision Not in Harmony With the Results of Antidumping Duty Administrative Review; Notice of Amended Final Results
• Large Diameter Welded Pipe From the Republic of Türkiye: Final Results of Antidumping Duty Administrative Review; 2023-2024
• Multilayered Wood Flooring From the People's Republic of China: Notice of Court Decision Not in Harmony With the Results of Countervailing Duty Administrative Review; Notice of Amended Final Results
• Implementing Certain Tariff-Related Elements of the United States-Japan Agreement
• Antidumping or Countervailing Duty Investigations, Orders, or Reviews: Certain Carbon and Alloy Steel Cut-to-Length Plate From Italy: Final Results and Final Partial Rescission of Antidumping Duty Administrative Review; 2023-2024
• Standard Steel Welded Wire Mesh From Mexico: Preliminary Affirmative Determination of Circumvention of the Antidumping Duty and Countervailing Duty Orders
• Sales at Less Than Fair Value; Determinations, Investigations, etc.: Methylene Diphenyl Diisocyanate From the People's Republic of China: Preliminary Affirmative Determination of Sales at Less-Than-Fair-Value, Postponement of Final Determination, and Extension of Provisional Measures
• Investigations; Determinations, Modifications, and Rulings, etc.: Certain Cameras, Camera Systems, and Accessories Used Therewith; Notice of Commission Determination To Review in Part a Final Initial Determination of Violation of Section 337; Schedule for Filing Written Submissions on Certain Issues Under Review and on Remedy, the Public Interest, and Bonding
• Certain Electrolyte Containing Beverages and Labeling and Packaging Thereof (II); Notice of Request for Submissions on the Public Interest
• Antidumping or Countervailing Duty Investigations, Orders, or Reviews: Wooden Cabinets and Vanities and Components Thereof From the People's Republic of China: Continuation of Antidumping Duty Order and Countervailing Duty
• Wooden Bedroom Furniture From the People's Republic of China: Final Results of Antidumping Duty Administrative Review; 2023
• Investigations; Determinations, Modifications, and Rulings, etc.: Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Granting Complainant's Motion To Amend the Complaint and Notice of Investigation
• Investigations; Determinations, Modifications, and Rulings, etc.: Certain Smart Televisions; Notice of a Commission Determination Not To Review an Initial Determination Granting a Joint Motion To Terminate the Investigation in Its Entirety Based Upon Settlement
• Ceramic Tile From China; Scheduling of Expedited Five-Year Reviews
• Unwrought Pallidum From Russia; Determinations
• Certain Disposable Vaporizer Devices; Notice of Request for Submissions on the Public Interest
• Antidumping or Countervailing Duty Investigations, Orders, or Reviews: Granular Polytetrafluoroethylene Resin From India: Final Results of the Countervailing Duty Administrative Review; 2023
• Sugar From Mexico: Continuation of Suspension of the Antidumping Duty Investigation
• Multilayered Wood Flooring From the People's Republic of China: Final Results of Countervailing Duty Administrative Review; 2022
• Glycine From Japan: Preliminary Results and Rescission, in Part, of Antidumping Duty Administrative Review, 2023-2024; and Preliminary Successor-in-Interest Determination
• Electrolytic Manganese Dioxide From the People's Republic of China: Final Results of the Expedited Third Sunset Review of the Antidumping Duty Order
• Sugar From Mexico: Continuation of Suspension of the Countervailing Duty Investigation
________________________________________________________________________________
USTR Seeks Public Comment on Section 301 Investigation of China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation - U.S. Trade Representative
WASHINGTON – Today (9/15/25), the Office of the United States Trade Representative announced that it is seeking public comment on whether any of the exclusions in effect in the Section 301 Investigation of China’s Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation warrant further extension. The 178 exclusions were extended on September 2, 2025 and are scheduled to expire on November 29, 2025.
As explained in a formal notice, USTR is requesting public comments on whether any of the 178 exclusions in effect warrant further extension beyond November 29, 2025.
________________________________________________________________________________
CBP Discovers Radioactive Isotopes in Food Shipment Containers at U.S. Ports, Prompting FDA Product Recall - U.S. Customs & Border Protection
WASHINGTON — U.S. Customs and Border Protection recently discovered and detained several international food shipping containers that contained unusual levels of cesium-137. CBP Officers at several U.S. ports made these discoveries, thanks to advanced nonintrusive inspection equipment and dedicated radiation detection systems. In addition, experts from CBP’s Laboratories and Scientific Services took part in the discovery and identification of the radioactive material and prevented these adulterated products from entering the United States.
"CBP and our partners are on the front lines ensuring that our imported food and other supplies are safe for American consumers,” said CBP Acting Executive Assistant Commissioner Diane J. Sabatino. "By leveraging our expert CBP professionals, advanced detection technologies, and close collaboration with the FDA, we are protecting public health and maintaining the integrity of the U.S. supply chain."
Cs-137 is a radioisotope of cesium that is man-made through nuclear reactions. This radioisotope is used worldwide in industrial, medical, and research applications. Trace amounts of Cs-137 can be found in the environment, including soil, food, and air.
As a result of these CBP discoveries, the U.S. Food and Drug Administration recently issued a food safety alert on certain frozen shrimp products. FDA advised the public not to eat, sell, or serve certain imported frozen shrimp as CBP continues to support FDA’s investigation of reports of Cs-137 contamination in shipping containers and frozen shrimp products processed by PT. Bahari Makmur Sejati of Indonesia. According to the FDA, at the level detected, Cs-137 would not pose an acute hazard to consumers but added that exposure to low-level radiation could have negative health impacts over time. The primary health concern following longer-term, repeated low-dose exposure of Cs-137 through the consumption of contaminated food or water is an elevated risk of cancer, resulting from damage to deoxyribonucleic acid within living cells of the body, according to the FDA.
It is believed that the Cs-137 contamination at PT. Bahari Makmur Sejati was caused by an accident outside of their direct control, based on information provided by Indonesian authorities. This accident remains under investigation, so no further details will be provided at this time.
NII and radiation detection technologies are integral to CBP’s mission to combat nuclear and radiological terrorism and prevent radioactive materials from entering the country and potentially reaching U.S. consumers. By leveraging NII equipment and radiation detection systems, CBP was able to identify Cs-137 in shipping containers at several major U.S. ports—Los Angeles, Long Beach, Houston, Savannah, Norfolk, Elizabeth, and Miami—before the contaminated products could enter U.S. commerce. CBP alerted FDA that containers at several U.S. ports included FDA regulated foods and these containers were detained. The first discovery took place at the Port of Los Angeles.
FDA has determined that products from PT. Bahari Makmur Sejati violate the Federal Food, Drug, and Cosmetic Act in that the products appear to have been prepared, packed, or held under insanitary conditions and may pose a safety concern. PT. Bahari Makmur Sejati has also been added to Import Alert 99-51 for chemical contamination to ensure that no adulterated shrimp products will enter U.S. commerce until the company resolves the conditions that led to the contamination.
CBP continues to engage U.S. authorities to ensure the safety of the food supply while coordinating with the FDA to prevent contaminated products from reaching consumers. Both agencies remain steadfast in their commitment to protecting public health and preserving the integrity of the U.S. food supply chain.
________________________________________________________________________________
Adoption and Procedures of the Section 232 Automobile Parts Tariff Inclusions Process - Federal Trade Register
AGENCY: Bureau of Industry and Security, U.S. Department of Commerce.
ACTION: Interim final rule.
SUMMARY: On March 26, 2025, the President issued Proclamation 10908, “Adjusting Imports of Automobiles and Automobile Parts into The United States” (Automobile Proclamation). The Automobile Proclamation required the Secretary of Commerce to establish a process for including additional automobile parts articles for passenger vehicles and light trucks within the scope of the tariffs imposed by the President in the Automobile Proclamation. This interim final rule (IFR) establishes the requisite process.
DATES: This rule is effective September 17, 2025. Comments on this interim final rule must be received by the International Trade Administration no later than November 3, 2025.
SUPPLEMENTARY INFORMATION:
________________________________________________________________________________
CBERA Has Minor Impact on U.S. Economy, Small but Positive Gains for Beneficiary Nations, Imports Decreased in 2024, Says USITC - U.S. International Trade Commission
The Caribbean Basin Economic Recovery Act (CBERA) continues to have a small effect on the overall U.S. economy but provides a positive benefit to participating countries, according to a new report released today, Caribbean Basin Economic Recovery Act: Impact on U.S. Industries and Consumers and on Beneficiary Countries, Twenty-Seventh Report, 2023–24, published by the U.S. International Trade Commission (USITC).
The USITC, an independent, nonpartisan, factfinding federal agency, today issued its 27th biennial report monitoring U.S. imports under the CBERA program. CBERA took effect on January 1, 1984, and offers preferential tariff treatment to most products of the 17 designated beneficiary countries in the Caribbean.
The publication covers the impact of CBERA, as modified by the Caribbean Basin Trade Partnership Act of 2000 (CBTPA) and the HOPE and HELP Acts, on the United States, with emphasis on 2023 and 2024. CBERA requires the USITC to prepare a report every two years that assesses both the actual and the probable future effect of the CBERA program on the U.S. economy generally and on U.S. imports, industries, and consumers. The report also covers the impact of the preference program on the beneficiary countries.
The following are highlights from the latest report:
• The overall effect of imports under the CBERA program on the U.S. economy generally and on U.S. imports, industries, and consumers continued to be small in 2023–24. For U.S. industries, the overall effect of the program on domestic production, employment, and operating profits was also small. The USITC identified two U.S. industries—methanol and T-shirts—that most likely have faced slight negative effects due to competition from CBERA imports. However, the estimated job losses in these two industries were outweighed by small increases in exports by U.S. yarn and fabric industries, whose products are used in the manufacture of apparel in Haiti.
• U.S. imports receiving preferential treatment under CBERA totaled $1.8 billion in 2024, a notable decline of 34.5 percent from $2.8 billion in 2022.
o The decline in imports under the program from 2022 to 2024 is attributed to reduced imports of textiles and apparel from Haiti; other mining and manufactured products, including methanol, from Trinidad and Tobago; and crude oil from Guyana.
• The CBERA program utilization rate has varied over time and across countries. The CBERA regional utilization rate declined from 50.9 percent in 2022 to 36.9 percent in 2023 and further to 27.7 percent in 2024.
o From 2022 to 2024, the region’s per capita exports of CBERA-eligible goods increased from $297 to $352—representing strong growth in the eligible export base.
o Factors that affected program usage included the ability to meet U.S. import requirements, uncertainty regarding the future of CBTPA and Haiti HOPE/HELP, preference margins, mismatch between productive capacity and program eligibility, and other supply and demand factors affecting export activity.
o From 1990 to 2024, the number of products exported by the CBERA region to the United States increased by 5 percent, led by Aruba, Guyana, Montserrat, and Belize. Depth of diversification varied across countries and declined slightly across the region, reflecting continued heavy concentration in methanol and energy products, as well as textiles and apparel. Between 1990–94 to 2020–24, exports under the CBERA program shifted toward products with higher R&D intensities.
o CBERA, particularly as modified by the HOPE and HELP Acts, has supported Haiti’s export diversification by fostering the growth of its apparel industry through preferential access to the U.S. market.
o Human capital, quality of institutions, cost of compliance, infrastructure, and trade liberalization were among the main factors influencing export diversification in CBERA beneficiaries.
• Investment for the near-term production and export of CBERA-eligible products is expected to have little impact on U.S. competitive industries and on the U.S. economy.
• The future impact of CBERA on the U.S. economy and domestic industries will likely remain small. CBERA countries currently supply only a small fraction of the U.S. market, a trend anticipated to continue in the near term.
• The HOPE and HELP programs are scheduled to expire on September 30, 2025. While expiration will likely have a small effect on the U.S. economy, witness testimony and economic modeling both anticipate substantial negative effects on the Haitian economy.
Caribbean Basin Economic Recovery Act: Impact on U.S. Industries and Consumers and on Beneficiary Countries, Twenty-Seventh Report, 2023–24 (Inv. No. 332-606, USITC Publication 5662, September 2025) is available on the USITC website. The USITC is also providing a limited modeling release underlying the analyses associated with this report on its website.